At #BIO2025, Michael Boyne, Co-founder and Principal at CatalystBio, spoke on clinical trial development in the U.S. as part of a panel examining regional approaches to conducting trials and the diverse opportunities available across different countries. The audience also heard valuable insights from Jinhak Kim… Read More
We’re excited to share that CatalystBio will be attending the CASSS – Sharing Science Solutions Cell and Gene Therapy Products (CGTP) Symposium 2025! Greta Wodarcyk and Michael Boyne will be representing our team, joining important discussions on the latest challenges and advancements in cell and… Read More
Yesterday, Greta Wodarcyk and Michael Boyne had the exciting opportunity to speak with a group of trainees in Northwestern University’s Biotechnology Training Program about a critical milestone in drug development: the path to an Investigational New Drug (IND) application. Their seminar, “Path to IND — Moving from the… Read More
The CatalystBio team is thrilled to announce the launch of our website! We’re excited to have a place where we can share more about who we are, what we do, and how we partner with innovators across the biotech landscape. From early-stage discovery through regulatory… Read More
We’re pleased to announce that Michael Boyne, Co-Founder and Principal at CatalystBio, will be sharing his expertise at the American Institute for Medical and Biological Engineering (AIMBE) Annual Meeting this Sunday, March 30th. Michael will be speaking on one of his favorite topics: Translating Discoveries from the Bench to the Bedside – bridging the critical gap between...Read More
As we ring in the New Year, we’re thrilled to announce the launch of CatalystBio, a global life sciences advisory firm! CatalystBio is designed to provide end-to-end advisory services and fractional leadership to companies to catalyze the product development lifecycle…Read More
Recent Comments